Celstrol 160 Tablet

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Celstrol 160 Tablet contains megestrol acetate, a progestogen (hormonal antineoplastic). Its labelling describes it for the treatment of hormone-dependent breast and endometrial cancer, and for low appetite and weight loss in advanced cancer or HIV. In breast cancer it is described as acting directly on the cancer or interacting with other hormones to stop growth and spread; in endometrial cancer it is described as replicating the effects of progesterone to relieve symptoms such as lower back pain, abnormal vaginal bleeding, and pain during sex.

Active ingredient
Megestrol acetate
Strength
160 mg
Dosage form
Oral tablet
Therapeutic class
Progestogen (hormonal antineoplastic)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the treatment of hormone-dependent breast cancer
  • Described for the treatment of endometrial cancer
  • Described for low appetite and weight loss in advanced cancer or HIV
  • Described as altering the hormones responsible for the growth and spread of breast cancer and replicating the effects of progesterone in endometrial cancer
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Swallowed whole; the tablet should not be crushed, chewed, or broken
  • Taken with or without a meal but at a fixed time
  • Taken for as long as the doctor has prescribed, per the dosage and interval

Described Side Effects

Commonly described side effects include:

  • Increased appetite
  • Weight gain
  • Hot flashes
  • High blood pressure
  • Constipation

These are described as commonly temporary. Any severe, persistent, or unexpected reaction requires prompt medical attention.

Precautions

  • Pregnant or breastfeeding patients should talk to the doctor
  • Regular blood tests for checking hormones and blood sugar levels may be carried out
  • Taken only for the duration, dosage, and interval prescribed by the doctor

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains megestrol acetate and is used for hormone-dependent breast and endometrial cancer and for appetite and weight loss in advanced cancer or HIV. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as swallowed whole with or without a meal at a fixed time, without crushing, chewing, or breaking, for the duration prescribed by the doctor.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services